Your browser doesn't support javascript.
loading
Cell Membrane Biomimetic Nano-Delivery Systems for Cancer Therapy.
Xia, Zhenxing; Mu, Weiwei; Yuan, Shijun; Fu, Shunli; Liu, Yongjun; Zhang, Na.
Affiliation
  • Xia Z; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Jinan 250012, China.
  • Mu W; Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan 250012, China.
  • Yuan S; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Jinan 250012, China.
  • Fu S; Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan 250012, China.
  • Liu Y; NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Jinan 250012, China.
  • Zhang N; Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Wenhua Xi Road, Jinan 250012, China.
Pharmaceutics ; 15(12)2023 Dec 13.
Article in En | MEDLINE | ID: mdl-38140108
ABSTRACT
Nano-delivery systems have demonstrated great promise in the therapy of cancer. However, the therapeutic efficacy of conventional nanomedicines is hindered by the clearance of the blood circulation system and the physiological barriers surrounding the tumor. Inspired by the unique capabilities of cells within the body, such as immune evasion, prolonged circulation, and tumor-targeting, there has been a growing interest in developing cell membrane biomimetic nanomedicine delivery systems. Cell membrane modification on nanoparticle surfaces can prolong circulation time, activate tumor-targeting, and ultimately improve the efficacy of cancer treatment. It shows excellent development potential. This review will focus on the advancements in various cell membrane nano-drug delivery systems for cancer therapy and the obstacles encountered during clinical implementation. It is hoped that such discussions will inspire the development of cell membrane biomimetic nanomedical systems.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceutics Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceutics Year: 2023 Document type: Article Affiliation country: Country of publication: